BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27119351)

  • 1. MicroRNA-126 induces autophagy by altering cell metabolism in malignant mesothelioma.
    Tomasetti M; Monaco F; Manzella N; Rohlena J; Rohlenova K; Staffolani S; Gaetani S; Ciarapica V; Amati M; Bracci M; Valentino M; Goodwin J; Nguyen M; Truksa J; Sobol M; Hozak P; Dong LF; Santarelli L; Neuzil J
    Oncotarget; 2016 Jun; 7(24):36338-36352. PubMed ID: 27119351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial function.
    Tomasetti M; Nocchi L; Staffolani S; Manzella N; Amati M; Goodwin J; Kluckova K; Nguyen M; Strafella E; Bajzikova M; Peterka M; Lettlova S; Truksa J; Lee W; Dong LF; Santarelli L; Neuzil J
    Antioxid Redox Signal; 2014 Nov; 21(15):2109-25. PubMed ID: 24444362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma.
    Cioce M; Ganci F; Canu V; Sacconi A; Mori F; Canino C; Korita E; Casini B; Alessandrini G; Cambria A; Carosi MA; Blandino R; Panebianco V; Facciolo F; Visca P; Volinia S; Muti P; Strano S; Croce CM; Pass HI; Blandino G
    Oncogene; 2014 Nov; 33(46):5319-31. PubMed ID: 24240684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-138-5p suppresses autophagy in pancreatic cancer by targeting SIRT1.
    Tian S; Guo X; Yu C; Sun C; Jiang J
    Oncotarget; 2017 Feb; 8(7):11071-11082. PubMed ID: 28052003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.
    Laszlo V; Hoda MA; Garay T; Pirker C; Ghanim B; Klikovits T; Dong YW; Rozsas A; Kenessey I; Szirtes I; Grusch M; Jakopovic M; Samarzija M; Brcic L; Kern I; Rozman A; Popper H; Zöchbauer-Müller S; Heller G; Altenberger C; Ziegler B; Klepetko W; Berger W; Dome B; Hegedus B
    J Pathol; 2015 Oct; 237(2):203-14. PubMed ID: 26011651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinoma.
    Zhang GM; Luo L; Ding XM; Dong DH; Li B; Ma XC; Sun LJ
    Mol Med Rep; 2016 Jun; 13(6):5029-2036. PubMed ID: 27108693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HEG1-responsive microRNA-23b regulates cell proliferation in malignant mesothelioma cells.
    Fujii T; Itami H; Uchiyama T; Morita K; Nakai T; Hatakeyama K; Sugimoto A; Shimada K; Tsuji S; Ohbayashi C
    Biochem Biophys Res Commun; 2020 Jun; 526(4):927-933. PubMed ID: 32284171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma.
    Cheng YY; Wright CM; Kirschner MB; Williams M; Sarun KH; Sytnyk V; Leshchynska I; Edelman JJ; Vallely MP; McCaughan BC; Klebe S; van Zandwijk N; Lin RC; Reid G
    Mol Cancer; 2016 Jun; 15(1):44. PubMed ID: 27245839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GAS5 long non-coding RNA in malignant pleural mesothelioma.
    Renganathan A; Kresoja-Rakic J; Echeverry N; Ziltener G; Vrugt B; Opitz I; Stahel RA; Felley-Bosco E
    Mol Cancer; 2014 May; 13():119. PubMed ID: 24885398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-induced MIR155 is a potent autophagy inducer by targeting multiple players in the MTOR pathway.
    Wan G; Xie W; Liu Z; Xu W; Lao Y; Huang N; Cui K; Liao M; He J; Jiang Y; Yang BB; Xu H; Xu N; Zhang Y
    Autophagy; 2014 Jan; 10(1):70-9. PubMed ID: 24262949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of CRISPR/Cas9-mediated NF2
    Wahiduzzaman M; Karnan S; Ota A; Hanamura I; Murakami H; Inoko A; Rahman ML; Hyodo T; Konishi H; Tsuzuki S; Hosokawa Y
    Cancer Sci; 2019 Jan; 110(1):180-193. PubMed ID: 30417500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA-XIST/microRNA-126 sponge mediates cell proliferation and glucose metabolism through the IRS1/PI3K/Akt pathway in glioma.
    Cheng Z; Luo C; Guo Z
    J Cell Biochem; 2020 Mar; 121(3):2170-2183. PubMed ID: 31680298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-30a-5p suppresses lung squamous cell carcinoma via ATG5 - mediated autophagy.
    Yang J; Rao S; Cao R; Xiao S; Cui X; Ye L
    Aging (Albany NY); 2021 Jul; 13(13):17462-17472. PubMed ID: 34253689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation-associated Silencing of microRNA-126 and its Host Gene EGFL7 in Malignant Pleural Mesothelioma.
    Andersen M; Trapani D; Ravn J; Sørensen JB; Andersen CB; Grauslund M; Santoni-Rugiu E
    Anticancer Res; 2015 Nov; 35(11):6223-9. PubMed ID: 26504055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-215-5p Treatment Suppresses Mesothelioma Progression via the MDM2-p53-Signaling Axis.
    Singh A; Bhattacharyya N; Srivastava A; Pruett N; Ripley RT; Schrump DS; Hoang CD
    Mol Ther; 2019 Sep; 27(9):1665-1680. PubMed ID: 31227395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-30e inhibits tumor growth and chemoresistance via targeting IRS1 in Breast Cancer.
    Liu MM; Li Z; Han XD; Shi JH; Tu DY; Song W; Zhang J; Qiu XL; Ren Y; Zhen LL
    Sci Rep; 2017 Nov; 7(1):15929. PubMed ID: 29162879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting YAP in malignant pleural mesothelioma.
    Zhang WQ; Dai YY; Hsu PC; Wang H; Cheng L; Yang YL; Wang YC; Xu ZD; Liu S; Chan G; Hu B; Li H; Jablons DM; You L
    J Cell Mol Med; 2017 Nov; 21(11):2663-2676. PubMed ID: 28470935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma.
    Reid G; Pel ME; Kirschner MB; Cheng YY; Mugridge N; Weiss J; Williams M; Wright C; Edelman JJ; Vallely MP; McCaughan BC; Klebe S; Brahmbhatt H; MacDiarmid JA; van Zandwijk N
    Ann Oncol; 2013 Dec; 24(12):3128-35. PubMed ID: 24148817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway.
    Zhao J; Li Z; Chen Y; Zhang S; Guo L; Gao B; Jiang Y; Tian W; Hao S; Zhang X
    Int J Oncol; 2019 Jan; 54(1):315-325. PubMed ID: 30387841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel genes and pathways modulated by syndecan-1: implications for the proliferation and cell-cycle regulation of malignant mesothelioma cells.
    Szatmári T; Mundt F; Heidari-Hamedani G; Zong F; Ferolla E; Alexeyenko A; Hjerpe A; Dobra K
    PLoS One; 2012; 7(10):e48091. PubMed ID: 23144729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.